Literature DB >> 12183547

Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.

Tyrone Bowes1, Eric R Wagner, Judith Boffey, Dawn Nicholl, Lynne Cochrane, Mustapha Benboubetra, Joe Conner, Keiko Furukawa, Koichi Furukawa, Hugh J Willison.   

Abstract

Guillain-Barré syndrome following Campylobacter jejuni infection is frequently associated with anti-ganglioside autoantibodies mediated by molecular mimicry with ganglioside-like oligosaccharides on bacterial lipopolysaccharide (LPS). The regulation of antibody responses to these T-cell-independent antigens is poorly understood, and only a minority of Campylobacter-infected individuals develop anti-ganglioside antibodies. This study investigates the response to gangliosides and LPS in strains of mice by using a range of immunization strategies. In normal mice following intraperitoneal immunization, antibody responses to gangliosides and LPS are low level but can be enhanced by the antigen format or coadministration of protein to recruit T-cell help. Class switching from the predominant immunoglobulin M (IgM) response to IgG3 occurs at low levels, suggesting B1-cell involvement. Systemic immunization results in poor responses. In GalNAc transferase knockout mice that lack all complex gangliosides and instead express high levels of GM3 and GD3, generation of anti-ganglioside antibodies upon immunization with either complex gangliosides or ganglioside-mimicking LPS is greatly enhanced and exhibits class switching to T-cell-dependent IgG isotypes and immunological memory, indicating that tolerance to self gangliosides is a major regulatory factor. Responses to GD3 are suppressed in knockout mice compared with wild-type mice, in which responses to GD3 are induced specifically by GD3 and as a result of polyclonal B-cell activation by LPS. The anti-ganglioside response generated in response to LPS is also dependent on the epitope density of the ganglioside mimicked and can be further manipulated by providing secondary signals via lipid A and CD40 ligation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183547      PMCID: PMC128228          DOI: 10.1128/IAI.70.9.5008-5018.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

Review 1.  Guillain Barré syndrome.

Authors:  J B Winer
Journal:  Mol Pathol       Date:  2001-12

2.  Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.

Authors:  C W Ang; N Yuki; B C Jacobs; M Koga; P A Van Doorn; P I Schmitz; F G Van Der Meché
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

3.  Techniques for encapsulating bioactive agents into liposomes.

Authors:  L D Mayer; M B Bally; M J Hope; P R Cullis
Journal:  Chem Phys Lipids       Date:  1986 Jun-Jul       Impact factor: 3.329

Review 4.  Biochemistry and Genetics of the ABO, Lewis, and P blood group systems.

Authors:  W M Watkins
Journal:  Adv Hum Genet       Date:  1980

Review 5.  Gangliosides: structure, isolation, and analysis.

Authors:  R W Ledeen; R K Yu
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.

Authors:  Patricia Guerry; Christine M Szymanski; Martina M Prendergast; Thomas E Hickey; Cheryl P Ewing; Dawn L Pattarini; Anthony P Moran
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 7.  Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes.

Authors:  S T Qureshi; P Gros; D Malo
Journal:  Trends Genet       Date:  1999-08       Impact factor: 11.639

Review 8.  The Lps locus: genetic regulation of host responses to bacterial lipopolysaccharide.

Authors:  S T Qureshi; P Gros; D Malo
Journal:  Inflamm Res       Date:  1999-12       Impact factor: 4.575

9.  Transgenic B lymphocytes expressing a human cold agglutinin escape tolerance following experimental infection of mice by Mycoplasma pulmonis.

Authors:  Séverine Havouis; Gérard Dumas; Isabelle Chambaud; Patrick Ave; Michel Huerre; Alain Blanchard; Guillaume Dighiero; Christine Pourcel
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

10.  Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Authors:  C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

View more
  38 in total

Review 1.  Antibody polyspecificity and neutralization of HIV-1: a hypothesis.

Authors:  Barton F Haynes; M Anthony Moody; Laurent Verkoczy; Garnett Kelsoe; S Munir Alam
Journal:  Hum Antibodies       Date:  2005

Review 2.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

3.  Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides.

Authors:  Tony Avril; Eric R Wagner; Hugh J Willison; Paul R Crocker
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.

Authors:  Joel Finney; Akiko Watanabe; Garnett Kelsoe; Masayuki Kuraoka
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

5.  Redemption of autoreactive B cells.

Authors:  Barton F Haynes; Laurent Verkoczy; Garnett Kelsoe
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-11       Impact factor: 11.205

6.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

7.  Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice.

Authors:  Denggao Yao; Rhona McGonigal; Jennifer A Barrie; Joanna Cappell; Madeleine E Cunningham; Gavin R Meehan; Simon N Fewou; Julia M Edgar; Edward Rowan; Yuhsuke Ohmi; Keiko Furukawa; Koichi Furukawa; Peter J Brophy; Hugh J Willison
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

8.  Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesis.

Authors:  Chien-Tsun Kuan; Jinli Chang; Jan-Eric Mansson; Jianjun Li; Charles Pegram; Pam Fredman; Roger E McLendon; Darell D Bigner
Journal:  BMC Dev Biol       Date:  2010-11-18       Impact factor: 1.978

Review 9.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

10.  GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice.

Authors:  Yukinari Kato; Chien-Tsun Kuan; Jinli Chang; Mika Kato Kaneko; Joanne Ayriss; Hailan Piao; Vidyalakshmi Chandramohan; Charles Pegram; Roger E McLendon; Pam Fredman; Jan-Eric Månsson; Darell D Bigner
Journal:  Biochem Biophys Res Commun       Date:  2009-11-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.